160 related articles for article (PubMed ID: 37535949)
21. Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study.
Norman I; Hjerpe A; Dillner J
BMJ Open; 2017 Dec; 7(12):e017070. PubMed ID: 29247086
[TBL] [Abstract][Full Text] [Related]
22. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.
Wong AK; Chan RC; Nichols WS; Bose S
Cancer; 2009 Feb; 115(4):823-32. PubMed ID: 19127558
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ.
Rabelo-Santos SH; Derchain SF; Villa LL; Costa MC; Sarian LO; do Amaral Westin MC; Kornegay J; Zeferino LC
Int J Gynecol Pathol; 2009 May; 28(3):272-8. PubMed ID: 19620946
[TBL] [Abstract][Full Text] [Related]
24. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
25. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests.
Zuo T; Levi AW; Lin Q; Abi-Raad R; Adeniran AJ; Cai G
Am J Clin Pathol; 2021 Sep; 156(4):569-576. PubMed ID: 33728437
[TBL] [Abstract][Full Text] [Related]
26. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Robertson M; Castle PE;
Int J Cancer; 2014 Aug; 135(3):624-34. PubMed ID: 24226935
[TBL] [Abstract][Full Text] [Related]
27. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
28. Significance of High-Risk Human Papillomavirus Testing for Atypical Glandular Cells on Cervical Cytology.
Komatsu H; Oishi T; Osaku D; Sawada M; Kudoh A; Nonaka M; Chikumi J; Sato S; Harada T
Acta Cytol; 2018; 62(5-6):405-410. PubMed ID: 29990964
[TBL] [Abstract][Full Text] [Related]
29. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
30. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
31. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
[TBL] [Abstract][Full Text] [Related]
32. Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
Söderlund-Strand A; Eklund C; Kemetli L; Grillner L; Törnberg S; Dillner J; Dillner L
Am J Obstet Gynecol; 2011 Aug; 205(2):145.e1-6. PubMed ID: 21658668
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
34. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
35. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
37. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
[TBL] [Abstract][Full Text] [Related]
38. Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high-risk human papillomavirus test results.
Pretorius RG; Belinson JL; Peterson P; Azizi F; Lo A
J Low Genit Tract Dis; 2013 Oct; 17(4):430-9. PubMed ID: 23595040
[TBL] [Abstract][Full Text] [Related]
39. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
[TBL] [Abstract][Full Text] [Related]
40. Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S50-5. PubMed ID: 23519305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]